Clinical Trials · NCT07092618
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
- Phase
- Phase 2/Phase 3
- Recruitment status
- Recruiting
- Sponsor
- AgelessRx
- Enrollment
- 150
- Start date
- Dec 2024
- Locations
- 1 site, United States
- Primary endpoint
- Evaluate the effectiveness of metformin in maintaining GLP1-induced weight loss in participants weaning off of Ozempic or Wegovy (or compounded semaglutide equivalent)